KR
Kirtida Radhakrishna Desai
About Kirtida Radhakrishna Desai
Data last updated:
Kirtida Radhakrishna Desai is a Director at Vivatest Lifescience Private Limited (since 2022), Director at Vivatest Research And Development Private Limited (since 2014) and Designated Partner at Respir Labs Llp (since 2025), and holds 1 more current directorship. The companies operate in Chemicals, Pharma and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹3.94 Cr; the largest is Vivatest Lifescience Private Limited at ₹2.28 Cr (FY 2024). Earlier, Kirtida Radhakrishna Desai was a Partner at Delnova Healthcare Llp (2017–2018) and Designated Partner at Kireshwar Traders Llp (2016–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Apr 2022 | 2022 | ₹2.28 Cr (FY 2024) | Active | |
| Director | 25 Nov 2014 | 2014 | ₹1.67 Cr (FY 2024) | Active | |
| Designated Partner | 15 Dec 2025 | 2025 | Active | ||
| Designated Partner | 30 Dec 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 10 Oct 2017 | 2017 | ₹5.74 Cr (FY 2023) | Active | |
| Designated Partner | 25 Jan 2016 | 2014 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Kirtida Radhakrishna Desai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Analesh Anand Desai | 06957572 | Vivatest Lifescience Private Limited , Vivatest Research And Development Private Limited | Director |
| Geeta Radhakrishna Desai | 07777819 | Vivatest Research And Development Private Limited | Additional Director |
| Tanvi Tushar Gaikar | 08467272 | Respir Labs Llp | Designated Partner |
| Arati Anand Desai | 10890801 | Ark Pharmacode Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kirtida Radhakrishna Desai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kirtida Radhakrishna Desai
Kirtida Radhakrishna Desai currently holds 4 directorships: Vivatest Lifescience Private Limited (Director, since 29 Apr 2022, revenue ₹2.28 Cr (FY 2024)); Vivatest Research And Development Private Limited (Director, since 25 Nov 2014, revenue ₹1.67 Cr (FY 2024)); Respir Labs Llp (Designated Partner, since 15 Dec 2025); Ark Pharmacode Llp (Designated Partner, since 30 Dec 2024).
Kirtida Radhakrishna Desai was first appointed on 25 Nov 2014 as Director at Vivatest Research And Development Private Limited. The most recent appointment on record is 15 Dec 2025 at Respir Labs Llp.
The 2 current companies of Kirtida Radhakrishna Desai that report revenue have a combined latest revenue of ₹3.94 Cr: Vivatest Lifescience Private Limited ₹2.28 Cr (FY 2024); Vivatest Research And Development Private Limited ₹1.67 Cr (FY 2024).
Kirtida Radhakrishna Desai held 2 earlier board appointments: Delnova Healthcare Llp (Partner, 10 Oct 2017 to 29 Sep 2018); Kireshwar Traders Llp (Designated Partner, 25 Jan 2016 to 18 Aug 2017).
The current boards of Kirtida Radhakrishna Desai's companies include Analesh Anand Desai (Vivatest Lifescience Private Limited), Geeta Radhakrishna Desai (Vivatest Research And Development Private Limited), Tanvi Tushar Gaikar (Respir Labs Llp), Arati Anand Desai (Ark Pharmacode Llp).